Betrixaban Impurity 4 | CAS 2370922-08-8 - Request Quote
Betrixaban Impurity 4
| SZ CAT No: | SZ-B051009 |
| CAS No | 2370922-08-8 |
| Mol.F. | C23H21ClN4O4 |
| Mol.Wt. | 452.9 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Betrixaban Impurity 4 is chemically N1-(2-((5-Chloropyridin-2-yl)carbamoyl)-4-methoxyphenyl)-N4,N4-dimethylterephthalamide. Betrixaban Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Betrixaban Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Betrixaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2370922-08-8
Purchase 2370922-08-8
Order 2370922-08-8
Enquire 2370922-08-8
price of 2370922-08-8
2370922-08-8 Supplier
2370922-08-8 Manufacturer
2370922-08-8 Exporter
buy high quality Betrixaban Impurity 4
Purchase Betrixaban Impurity 4
Betrixaban Impurity 4 suppliers
Betrixaban Impurity 4 manufacturers
Betrixaban Impurity 4 price
Order Betrixaban Impurity 4
Enquire Betrixaban Impurity 4
Betrixaban Impurity 4 cost
Betrixaban Impurity 4 Supplier
Betrixaban Impurity 4 Distributor
Betrixaban Impurity 4 for Method Validation
Betrixaban Reference Standard
Betrixaban Impurity 4 for ANDA Filing
Betrixaban Impurity 4 for Forced Degradation Studies
Betrixaban Impurity 4 Identification Standards
Betrixaban Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.